Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikkel B Christensen

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Expert Opinion on Emerging Drugs|June 28, 2021
Emerging glucagon-like peptide 1 receptor agonists for the treatment of obesityMathies M Jepsen, Mikkel B Christensen
Nucleic Acids Research|September 6, 2005
Biased exon/intron distribution of cryptic and de novo 3' splice sitesJana Královicová, Mikkel B Christensen, Igor Vorechovský
Clinical Pharmacokinetics|January 5, 2017
Clinical Pharmacokinetics and Pharmacodynamics of AlbiglutideAndreas Brønden, Filip K Knop, Mikkel B Christensen
Diabetes, Obesity & Metabolism|February 23, 2021
An overview of obesity mechanisms in humans: Endocrine regulation of food intake, eating behaviour and common determinants of body weightSimone Theilade, Mikkel B Christensen, Tina Vilsbøll, et al.
Health Services Research and Managerial Epidemiology|September 25, 2018
General Practitioners' Barriers Toward Medication Reviews in Polymedicated Multimorbid Patients: How can a Focus on the Pharmacotherapy in an Outpatient Clinic Support GPs?Jannie Laursen, Jonatan Kornholt, Cecilie Betzer, et al.
STAR Protocols|February 28, 2023
Protocol for assessing the effects of exogenous hormone administration on human postprandial glucose metabolism, appetite sensations, and food intakeChristoffer A Hagemann, Lærke S Gasbjerg, Mikkel B Christensen, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Glucose-dependent insulinotropic polypeptide: blood glucose stabilizing effects in patients with type 2 diabetesMikkel B Christensen, Salvatore Calanna, Jens J Holst, et al.
Journal of Evaluation in Clinical Practice|August 9, 2018
Effect of a medicines management model on medication-related readmissions in older patients admitted to a medical acute admission unit-A randomized controlled trialTrine Graabaek, Ulla Hedegaard, Mikkel B Christensen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 6, 2021
Pancreatic polypeptide: A potential biomarker of glucose-dependent insulinotropic polypeptide receptor activation in vivoSimon Veedfald, Natasha C Bergmann, Tina Vilsbøll, et al.
Peptides|November 5, 2019
GIP's involvement in the pathophysiology of type 2 diabetesMikkel B Christensen, Lærke S Gasbjerg, Sebastian M Heimbürger, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Expert Opinion on Emerging Drugs|June 28, 2021
Emerging glucagon-like peptide 1 receptor agonists for the treatment of obesityMathies M Jepsen, Mikkel B Christensen
Nucleic Acids Research|September 6, 2005
Biased exon/intron distribution of cryptic and de novo 3' splice sitesJana Královicová, Mikkel B Christensen, Igor Vorechovský
Clinical Pharmacokinetics|January 5, 2017
Clinical Pharmacokinetics and Pharmacodynamics of AlbiglutideAndreas Brønden, Filip K Knop, Mikkel B Christensen
Diabetes, Obesity & Metabolism|February 23, 2021
An overview of obesity mechanisms in humans: Endocrine regulation of food intake, eating behaviour and common determinants of body weightSimone Theilade, Mikkel B Christensen, Tina Vilsbøll, et al.
Health Services Research and Managerial Epidemiology|September 25, 2018
General Practitioners' Barriers Toward Medication Reviews in Polymedicated Multimorbid Patients: How can a Focus on the Pharmacotherapy in an Outpatient Clinic Support GPs?Jannie Laursen, Jonatan Kornholt, Cecilie Betzer, et al.
STAR Protocols|February 28, 2023
Protocol for assessing the effects of exogenous hormone administration on human postprandial glucose metabolism, appetite sensations, and food intakeChristoffer A Hagemann, Lærke S Gasbjerg, Mikkel B Christensen, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Glucose-dependent insulinotropic polypeptide: blood glucose stabilizing effects in patients with type 2 diabetesMikkel B Christensen, Salvatore Calanna, Jens J Holst, et al.
Journal of Evaluation in Clinical Practice|August 9, 2018
Effect of a medicines management model on medication-related readmissions in older patients admitted to a medical acute admission unit-A randomized controlled trialTrine Graabaek, Ulla Hedegaard, Mikkel B Christensen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 6, 2021
Pancreatic polypeptide: A potential biomarker of glucose-dependent insulinotropic polypeptide receptor activation in vivoSimon Veedfald, Natasha C Bergmann, Tina Vilsbøll, et al.
Peptides|November 5, 2019
GIP's involvement in the pathophysiology of type 2 diabetesMikkel B Christensen, Lærke S Gasbjerg, Sebastian M Heimbürger, et al.
Pageof 7